Standard Repeat Biopsies During Active Surveillance for Prostate Cancer: Are They Necessary in the Magnetic Resonance Imaging Era?
Where this comes from
- Record sourced from PubMed, PMID 39327115.
- Also identified by DOI 10.1016/j.eururo.2024.09.014.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Active surveillance (AS) remains an important part of the efforts to decrease overtreatment of prostate cancer. The increasing use of magnetic resonance imaging (MRI) can reduce the need for repeat biopsy during AS. If MRI findings remain unchanged and clinical characteristics such as prostate-specific antigen density are favourable, the relative risks and benefits of repeat biopsy should be discussed with individual patients.
Medical subject headings
- Prostatic Neoplasms
- Watchful Waiting
- Magnetic Resonance Imaging